Thank you. The Minister is correct; and non-insured health benefits are used as a means for formulary design. However, that system does have some gaping holes in the process and currently, right now, if a patient was to question viability of a drug being covered, it goes to Inuvik to extended benefits for review and it is reviewed, hopefully, by an independent source or a professional source. Does the Minister have information whether or not there is a process for a review that goes outside the formulary design of intention? Thank you.
Daryl Dolynny on Question 144-17(3): Off-Label Use Of Prescription Drugs
In the Legislative Assembly on June 13th, 2012. See this statement in context.
Question 144-17(3): Off-Label Use Of Prescription Drugs
Oral Questions
June 12th, 2012
See context to find out what was said next.